Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,078 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Drug Repurposing And Second Medical Use Patents: Unlocking New Value From Known Medicines

    Pharmaceutical companies are increasingly turning to drug repurposing to accelerate development timelines and reduce risk, identifying new therapeutic applications for known compounds. This strategy offers significant clinical and commercial advantages, from faster patient access to extended product lifecycles, but raises complex questions about intellectual property protection and regulatory exclusivity. The article examines how second medical use patents and strategic IP planning enable innovators to secu
    United KingdomIntellectual Property
    Potter Clarkson LLP
    Potter Clarkson LLP
  • Article

    From Certificates To Courts: Litigating Second Medical Use Patents

    The dubiety of second medical use patents has not been limited to which further therapeutic treatments qualify for exclusive rights...
    United KingdomIntellectual Property
Dennemeyer & Associates S.A.
Dennemeyer & Associates S.A.
  • Article

    How McDonald's Lost Its Big Mac Trade Mark

    How did Irish burger chain Supermac's manage to get the Big Mac trade mark cancelled across the EU? The answer lies in the lack of evidence presented by McDonald's as Daniel Bailey explains.
    United KingdomIntellectual Property
    Marks & Clerk
    Marks & Clerk
  • Article

    Patent Innovations To Combat Climate Change

    Which Patent Innovations are supporting the race to maintain sustainability? The ‘E' in ESG stands for environmental, and most fortune 500 companies have pledged to reduce their impact on climate.
    United KingdomIntellectual Property
    Cipher
    Cipher
  • Article

    ASA And CAP Annual Report 2025: Smarter, Proactive Advertising Regulation

    The ASA and CAP's Annual Report 2025 reveals a fundamental transformation in UK advertising regulation, with AI-enabled monitoring now scanning nearly 60 million online ads and proactive enforcement overtaking reactive complaints work. From prescription weight-loss medicines to influencer disclosures and green claims, the report exposes critical compliance gaps across multiple sectors while signaling an era of unprecedented data-driven scrutiny.
    United KingdomMedia, Telecoms, IT, Entertainment
    Global Advertising Lawyers Alliance (GALA)
    Global Advertising Lawyers Alliance (GALA)
  • Article

    ASA And CAP Annual Report 2025: Smarter, Proactive Advertising Regulation

    The ASA and CAP's Annual Report 2025 reveals a fundamental shift in UK advertising regulation, with AI-enabled monitoring now scanning nearly 60 million online ads and proactive enforcement overtaking reactive complaints work. From prescription weight-loss medicines to influencer disclosures and green claims, the report exposes critical compliance gaps while showcasing how data-driven regulation is reshaping advertiser accountability across digital platforms.
    United KingdomMedia, Telecoms, IT, Entertainment
    Lewis Silkin
    Lewis Silkin
  • Article

    Digital Transformation In Biopharma: Time For A Sea Change In Strategy

    Deloitte recently conducted a survey with the MIT Sloan Management Review to assess the digital maturity of companies across a wide variety of industries.
    United KingdomStrategy
    Deloitte
    Deloitte
  • Article

    ''Brexit'': Impact On Compliance With EU Chemicals Legislation

    The impact of the referendum in the United Kingdom (''UK'') remains very unclear and this is not different for the chemicals sector.
    United KingdomAntitrust/Competition Law
    Fieldfisher
    Fieldfisher
  • Article

    Excessive Pricing, ‘Pay-For-Delay' And Rebates: A New Era Of Enforcement In The Pharmaceutical Industry

    The European Commission (EC) and other national competition authorities (NCAs) have traditionally shied away from investigating allegations of excessive pricing and appearing as price regulators.
    European UnionAntitrust/Competition Law
    A&O Shearman
    A&O Shearman
  • Article

    SPCs For Combination Products – Will CJEU Need To Look Again?

    National courts have diverged on the interpretation of the EU Court of Justice’s latest decisions on SPCs for combination products – in particular on whether data in the application as filed are required for a combination product to meet the CJEU’s test of “falling under the invention” of the basic patent and be eligible for SPC protection in the EU.
    GlobalIntellectual Property
    HGF Law
    HGF Law
  • Article

    Competition Law Focus On Healthcare Markets Continues With Welcome (But Limited) CMA Guidance On Collaboration For Combination Therapies

    On 17 November 2023, the Competition and Markets Authority (CMA) published guidance offering reassurance that collaborations between medicine manufactures o make combination therapies available on the NHS...
    United KingdomAntitrust/Competition Law
    Bristows LLP
    Bristows LLP
  • Article

    The Future Of Medical Cannabis: Regulation, Capital Raising, And Investments

    This article was written for Medical Cannabis Network Quarterly (issue 4) and also appears on the website of Medical Cannabis Network, September 2020.
    United KingdomCannabis & Hemp
    Hill Dickinson
    Hill Dickinson
  • Article

    Revitalizing CPG Performance: Lessons From Market Leaders

    Major consumer products companies (CPGs) face tough terrain. The first half of 2024 saw several formerly thriving companies report disappointing results, and most experience a drop in sales volumes...
    United KingdomConsumer Protection
    AlixPartners Asia LLC
    AlixPartners Asia LLC
  • Article

    Buying A Vineyard Or Winery

    Buying a vineyard or a winery involves acquiring a bundle of assets. Land is at the heart of the transaction, but you may also be buying crops, buildings, subsidies, goodwill, and...
    United KingdomCorporate/Commercial Law
    Forsters
    Forsters
  • Article

    Retailers: Are You Prepared For The Ban On Single-Use Plastics?

    Under new Environmental Protection regulations, the UK government has announced its plans to ban single-use plastic. Our article looks at what items will be banned and how retailers can prepare.
    United KingdomEnvironment
    Foot Anstey
    Foot Anstey
  • Article

    How Grocers Can Maintain Their Lead In Fresh Food As Nationals Spend Big To Narrow The Gap

    Consumers make three core demands when it comes to the perimeter of the grocery store: They want quality product, reasonably priced, reliably in stock. As grocers create their go-to-market strategies...
    United KingdomFood, Drugs, Healthcare, Life Sciences
    AlixPartners Asia LLC
    AlixPartners Asia LLC
  • Article

    MHRA Launches Consultation On Modernising The Definition Of Gene Therapy Medicinal Products

    The MHRA has launched a consultation on proposed updates to the definition of gene therapy medicinal products (“GTMPs”) under the UK Human Medicines Regulations 2012 (“HMRs”).
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    New Year Update: Incoming Changes To UK Regulation Of Clinical Trials

    2025 promises to be a year of further advancements in the UK's life sciences sector and one important area of on-going development is the regulation of clinical trials.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Pharmacy Brief - June 2013

    The Law Commission has published a review of the Regulation of Health Care Professionals through which it proposes to bring the regulation of all healthcare and social care professionals into line with each other.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Charles Russell Speechlys LLP
    Charles Russell Speechlys LLP
  • Article

    Safeguarding Investments: The Value Of IP Due Diligence In Food & Drink

    All investors have a keen eye for an investment opportunity and the finer details of a deal. However, experience has taught us that when you are being pitched a new food or drink product...
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Potter Clarkson LLP
    Potter Clarkson LLP
  • Showing 881–900 of 1078 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics